Daniel J. Brennan

2020

In 2020, Daniel J. Brennan earned a total compensation of $3.7M as Executive Vice President and Chief Financial Officer at Boston Scientific, a 9% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$99,172
Non-Equity Incentive Plan$455,206
Option Awards$624,992
Salary$560,422
Stock Awards$1,907,997
Other$21,204
Total$3,668,993

Brennan received $1.9M in stock awards, accounting for 52% of the total pay in 2020.

Brennan also received $99.2K of change in pension value and nonqualified deferred compensation earnings, $455.2K in non-equity incentive plan, $625K in option awards, $560.4K in salary and $21.2K in other compensation.

Rankings

In 2020, Daniel J. Brennan's compensation ranked 3,156th out of 13,090 executives tracked by ExecPay. In other words, Brennan earned more than 75.9% of executives.

ClassificationRankingPercentile
All
3,156
out of 13,090
76th
Division
Manufacturing
1,231
out of 5,621
78th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
143
out of 799
82nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
78
out of 495
84th
Industry
Surgical and Medical Instruments and Apparatus
53
out of 313
83rd

Pay ratio

Daniel J. Brennan's Pay$3,668,993
Median Employee's Pay$59,332
Pay Ratio

62

to 1

In 2020, the annual total compensation of Daniel J. Brennan was $3,668,993.

The annual total compensation of the median employee at Boston Scientific was $59,332.

The ratio of Daniel J. Brennan's pay to the pay of median employee was therefore 62 to one.

Source: SEC filing on March 24, 2021.

Brennan's colleagues

We found four more compensation records of executives who worked with Daniel J. Brennan at Boston Scientific in 2020.

2020

Michael Mahoney

Boston Scientific

Chief Executive Officer

2020

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Interventional Cardiology

2020

Edward Mackey

Boston Scientific

Executive Vice President, Operations

2020

Jeffrey Mirviss

Boston Scientific

Executive Vice President and President, Peripheral Interventions

News

You may also like